(Reuters) – Indivior said on Tuesday its finance chief Ryan Preblick will step down as a director as the British drugmaker makes changes to its board following pressure from no.2 shareholder Oaktree Capital.
The maker of opioid addiction treatment Sublocade also appointed Robert Schriesheim and Joe Ciaffoni as independent non-executive directors, and said it has agreed to move towards a more standard U.S. system of remuneration for directors following its recent primary listing in New York.
(This story has been corrected to say Preblick is stepping down as director, not resigning from CFO post, in the headline and paragraph 1)
(Reporting by Yadarisa Shabong in Bengaluru; Editing by Sherry Jacob-Phillips)
